Tiny eye implants battle blinding pressure in major trial
NCT ID NCT06066645
Summary
This study is testing whether adding a slow-release drug implant works better than a drainage device alone for controlling eye pressure in glaucoma. About 230 adults with glaucoma will receive either the combination treatment or just the drainage device, then be followed for one year. The goal is to find a more effective long-term approach to managing this sight-threatening condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Study Site
RECRUITINGColorado Springs, Colorado, 80907, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.